Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib for maintenance therapy in moderate to severe Crohn's disease
NCT01393899Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2012
- Primary completion
- Jul 2015
- Countries
- 17
01
Overview
A Phase 2 trial of tofacitinib oral solution in Crohn's disease, sponsored by Pfizer. Started Mar 2012; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01393899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393899.